lobbying_filings_raw: cc293db6-e86d-4128-acb7-d82e5c48e9c2
This data as json
| filing_uuid | filing_type | registrant_id | registrant_name | client_id | client_name | filing_year | filing_period | received_date | amount_reported | is_amendment | is_no_activity | is_termination | raw_json | registrant_state | registrant_country | registrant_house_id | client_state | client_ppb_state | client_country | client_ppb_country | client_general_description | client_government_entity | affiliated_org_count | client_entity_id | client_government_unit_id | client_match_method | client_match_confidence |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| cc293db6-e86d-4128-acb7-d82e5c48e9c2 | Q3 | 69674 | NATIONAL MULTIPLE SCLEROSIS SOCIETY | 164353 | NATIONAL MULTIPLE SCLEROSIS SOCIETY | 2018 | third_quarter | 2018-10-22T11:18:28.663000-04:00 | 105700.0 | 0 | 0 | 0 | {"url": "https://lda.senate.gov/api/v1/filings/cc293db6-e86d-4128-acb7-d82e5c48e9c2/", "filing_uuid": "cc293db6-e86d-4128-acb7-d82e5c48e9c2", "filing_type": "Q3", "filing_type_display": "3rd Quarter - Report", "filing_year": 2018, "filing_period": "third_quarter", "filing_period_display": "3rd Quarter (July 1 - Sep 30)", "filing_document_url": "https://lda.senate.gov/filings/public/filing/cc293db6-e86d-4128-acb7-d82e5c48e9c2/print/", "filing_document_content_type": "text/html", "income": null, "expenses": "105700.00", "expenses_method": "a", "expenses_method_display": "Method A - Reporting amounts using LDA definitions only", "posted_by_name": "Leslie Ritter", "dt_posted": "2018-10-22T11:18:28.663000-04:00", "termination_date": null, "registrant_country": "United States of America", "registrant_ppb_country": null, "registrant_address_1": "1100 NEW YORK AVENUE, NW, #440 E", "registrant_address_2": null, "registrant_different_address": false, "registrant_city": "WASHINGTON", "registrant_state": "DC", "registrant_zip": "20005", "registrant": {"id": 69674, "url": "https://lda.senate.gov/api/v1/registrants/69674/", "house_registrant_id": 35789, "name": "NATIONAL MULTIPLE SCLEROSIS SOCIETY", "description": null, "address_1": "1100 NEW YORK AVENUE, NW, #440 E", "address_2": null, "address_3": null, "address_4": null, "city": "WASHINGTON", "state": "DC", "state_display": "District of Columbia", "zip": "20005", "country": "US", "country_display": "United States of America", "ppb_country": "US", "ppb_country_display": "United States of America", "contact_name": "BRYANT ROBINSON", "contact_telephone": "+1 978-500-8654", "dt_updated": "2026-01-08T17:01:25.844593-05:00"}, "client": {"id": 164353, "url": "https://lda.senate.gov/api/v1/clients/164353/", "client_id": 12, "name": "NATIONAL MULTIPLE SCLEROSIS SOCIETY", "general_description": null, "client_government_entity": false, "client_self_select": true, "state": "DC", "state_display": "District of Columbia", "country": "US", "country_display": "United States of America", "ppb_state": "DC", "ppb_state_display": "District of Columbia", "ppb_country": "US", "ppb_country_display": "United States of America", "effective_date": "2007-08-10"}, "lobbying_activities": [{"general_issue_code": "BUD", "general_issue_code_display": "Budget/Appropriations", "description": "- Department of Defense Appropriations Act, 2019, support $12 million for the MSRP.\n- Department of Labor, Health and Human Services and Education and Related Agencies Appropriations Act, 2019, support $39.3 billion for the National Institutes of Health (NIH); $8.445 billion for the Centers for Disease Control and Prevention inclusive of $5 million to establish the National Neurological Conditions Surveillance System; $5 million for the Lifespan Respite Care Program; $150 million for the Patient-Centered Outcomes Research Institute; $454 million for the Agency for Healthcare Research and Quality; and robust funding for the SSAs administrative budget.\n- Department of Agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations Act, 2019, support - Department of Agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations Act, 2019, support $3.32 billion for the Food and Drug Administration.", "foreign_entity_issues": "", "lobbyists": [{"lobbyist": {"id": 51107, "prefix": null, "prefix_display": null, "first_name": "LAURA", "nickname": null, "middle_name": null, "last_name": "WEIDNER", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}, {"lobbyist": {"id": 63338, "prefix": null, "prefix_display": null, "first_name": "JOHN", "nickname": null, "middle_name": null, "last_name": "WYLAM", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}, {"lobbyist": {"id": 64872, "prefix": null, "prefix_display": null, "first_name": "LESLIE", "nickname": null, "middle_name": null, "last_name": "RITTER", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}], "government_entities": [{"id": 30, "name": "Army, Dept of (Other)"}, {"id": 136, "name": "Centers For Medicare and Medicaid Services (CMS)"}, {"id": 135, "name": "Food & Drug Administration (FDA)"}, {"id": 2, "name": "HOUSE OF REPRESENTATIVES"}, {"id": 1, "name": "SENATE"}]}, {"general_issue_code": "MED", "general_issue_code_display": "Medical/Disease Research/Clinical Labs", "description": "S.2987/ H.R. 5515, National Defense Authorization Act for FY19, support funding and scope of Congressionally Directed Medical Research Programs within the Department of Defense.", "foreign_entity_issues": "", "lobbyists": [{"lobbyist": {"id": 63338, "prefix": null, "prefix_display": null, "first_name": "JOHN", "nickname": null, "middle_name": null, "last_name": "WYLAM", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}, {"lobbyist": {"id": 64872, "prefix": null, "prefix_display": null, "first_name": "LESLIE", "nickname": null, "middle_name": null, "last_name": "RITTER", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}], "government_entities": [{"id": 30, "name": "Army, Dept of (Other)"}, {"id": 136, "name": "Centers For Medicare and Medicaid Services (CMS)"}, {"id": 135, "name": "Food & Drug Administration (FDA)"}, {"id": 2, "name": "HOUSE OF REPRESENTATIVES"}, {"id": 1, "name": "SENATE"}]}, {"general_issue_code": "HCR", "general_issue_code_display": "Health Issues", "description": "-Bipartisan Health Care Stabilization Act, support bipartisan efforts led by Senators Alexander and Murray to stabilize and improve the individual health insurance market while protecting people with chronic conditions.\n-H.R. 2439/S. 1131, FAIR Drug Pricing Act, support passage.\n- H.R. 2212/ S. 974, Creating and Restoring Equal Access To Equivalent Samples Act of 2017 (CREATES Act), support passage.\n-H.R. 2077, Restoring Patients Voice Act, support passage.\n-S. 637, Creating Transparency to Have Drug Rebates Unlocked (C-THRU) Act, support passage.\n-H.R. 4841/S. 2908, Standardizing Electronic Prior Authorization for Safe Prescribing Act, support passage.\n- H.R. 2051, Fair Access for Safe and Timely Generics Act of 2017 (FAST Generics Act), support passage.\n-H.R. 750, support passage of the Ensuring Access to Quality Complex Rehabilitation Technology Act.\n-H.R. 1361/S. 486/H.R. 3730, support passage to protect access to complex rehabilitative technology accessories.\n-H.R. 2535/S. 1188, Lifespan Respite Care Reauthorization Act, support reauthorization of the Lifespan Respite Care Program.\n-HR 2575/S. 1909, Beneficiary Enrollment Notification and Eligibility Simplification (BENES) Act", "foreign_entity_issues": "", "lobbyists": [{"lobbyist": {"id": 51107, "prefix": null, "prefix_display": null, "first_name": "LAURA", "nickname": null, "middle_name": null, "last_name": "WEIDNER", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}, {"lobbyist": {"id": 66332, "prefix": null, "prefix_display": null, "first_name": "KIMBERLY", "nickname": null, "middle_name": null, "last_name": "CALDER", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}, {"lobbyist": {"id": 64872, "prefix": null, "prefix_display": null, "first_name": "LESLIE", "nickname": null, "middle_name": null, "last_name": "RITTER", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}, {"lobbyist": {"id": 63338, "prefix": null, "prefix_display": null, "first_name": "JOHN", "nickname": null, "middle_name": null, "last_name": "WYLAM", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}], "government_entities": [{"id": 30, "name": "Army, Dept of (Other)"}, {"id": 136, "name": "Centers For Medicare and Medicaid Services (CMS)"}, {"id": 135, "name": "Food & Drug Administration (FDA)"}, {"id": 2, "name": "HOUSE OF REPRESENTATIVES"}, {"id": 1, "name": "SENATE"}]}, {"general_issue_code": "CIV", "general_issue_code_display": "Civil Rights/Civil Liberties", "description": "H.R. 620, ADA Education and Reform Act, oppose passage.", "foreign_entity_issues": "No foreign interests.", "lobbyists": [{"lobbyist": {"id": 51107, "prefix": null, "prefix_display": null, "first_name": "LAURA", "nickname": null, "middle_name": null, "last_name": "WEIDNER", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}], "government_entities": [{"id": 30, "name": "Army, Dept of (Other)"}, {"id": 136, "name": "Centers For Medicare and Medicaid Services (CMS)"}, {"id": 135, "name": "Food & Drug Administration (FDA)"}, {"id": 2, "name": "HOUSE OF REPRESENTATIVES"}, {"id": 1, "name": "SENATE"}]}, {"general_issue_code": "TRA", "general_issue_code_display": "Transportation", "description": "-H.R. 5004/S. 1318, Air Carrier Access Amendments Act, support passage.\n-Reauthorization of the Federal Aviation Administration, support provisions to improve air travel for passengers with disabilities.", "foreign_entity_issues": "", "lobbyists": [{"lobbyist": {"id": 51107, "prefix": null, "prefix_display": null, "first_name": "LAURA", "nickname": null, "middle_name": null, "last_name": "WEIDNER", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}], "government_entities": [{"id": 30, "name": "Army, Dept of (Other)"}, {"id": 136, "name": "Centers For Medicare and Medicaid Services (CMS)"}, {"id": 135, "name": "Food & Drug Administration (FDA)"}, {"id": 2, "name": "HOUSE OF REPRESENTATIVES"}, {"id": 1, "name": "SENATE"}]}, {"general_issue_code": "MMM", "general_issue_code_display": "Medicare/Medicaid", "description": "-H.R. 750, support passage of the Ensuring Access to Quality Complex Rehabilitation Technology Act.\n-H.R. 1361/S. 486/H.R. 3730, support passage to protect access to complex rehabilitative technology accessories.\n-HR 2575/S. 1909, Beneficiary Enrollment Notification and Eligibility Simplification (BENES) Act", "foreign_entity_issues": "", "lobbyists": [{"lobbyist": {"id": 63338, "prefix": null, "prefix_display": null, "first_name": "JOHN", "nickname": null, "middle_name": null, "last_name": "WYLAM", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}, {"lobbyist": {"id": 66332, "prefix": null, "prefix_display": null, "first_name": "KIMBERLY", "nickname": null, "middle_name": null, "last_name": "CALDER", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}, {"lobbyist": {"id": 51107, "prefix": null, "prefix_display": null, "first_name": "LAURA", "nickname": null, "middle_name": null, "last_name": "WEIDNER", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}], "government_entities": [{"id": 30, "name": "Army, Dept of (Other)"}, {"id": 136, "name": "Centers For Medicare and Medicaid Services (CMS)"}, {"id": 135, "name": "Food & Drug Administration (FDA)"}, {"id": 2, "name": "HOUSE OF REPRESENTATIVES"}, {"id": 1, "name": "SENATE"}]}], "conviction_disclosures": [], "foreign_entities": [], "affiliated_organizations": []} | DC | US | 35789 | DC | DC | US | US | 0 | 0 | 100161 | normalized_name_dc_fallback | 0.8 |